SHANGHAI PHARMACEUTICALS HOLDINGS CO., LTD. (SHPMY) Business News Aug. 06, 2026, 14:20 UTC Clinical trial NCT05944224: primary completion date: 2026-05-31 → 2026-12-31. Full text
Register to leave comments News bot Aug. 6, 2026, 2:27 p.m. 📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical